Gads, a hematopoietic-lineage-specific Grb2 family member, is involved in the signaling mediated by the TCR through its interactions with SLP-76 and LAT. Here, we generated transgenic mice expressing Grf40-dSH2, an SH2-deleted dominant-negative form of Gads, which is driven by the lck proximal promoter. The total number of thymocytes was profoundly reduced in the transgenic mice, whereas in the double-negative (CD4 -CD8 -) thymocyte subset, in particular the CD25 ⍣ CD44 -pre-T cell population, it was significantly increased. However, CD5 expression, which is mediated by pre-TCR stimulation, was significantly suppressed on the CD4 -CD8 -thymocytes of the transgenic mice. Furthermore, the SLP-76-dependent signaling was markedly suppressed as well. These data suggest that Gads plays an important role in the pre-TCR as well as TCR signaling in thymocytes.
Introduction
Stimulation of the TCR results in the sequential activation of upon TCR stimulation through its SH2 domain (10-12). We demonstrated that the binding ability of Gads to SLP-76 is the Src family and Syk family protein tyrosine kinases (PTK), including Lck, Fyn and ZAP-70, which trigger the calciumsignificantly stronger than that of Grb2. Moreover, an SH2-deletion mutant of Gads, Grf40-dSH2, induced a stronger dependant and Ras-dependant signaling pathways (1-3). The TCR-induced calcium flux depends on the tyrosine inhibition of TCR-mediated signaling in Jurkat cells than did an SH2-deletion mutant of Grb2 (11). Furthermore, Gads was phosphorylation and activation of phospholipase C (PLC)-γ1, while the activation of Ras is thought to be initiated by the recently revealed to be essential for SLP-76 to localize to membrane lipid rafts after TCR stimulation (16). These data recruitment of a Grb2-Sos complex to the membrane (4,5). Two adapter/linker molecules, SLP-76 and LAT, are indispenssuggest that Gads plays a critical role in TCR signaling through an interaction with SLP-76 and LAT that is more able for coupling the PTK that mediate TCR signals to their downstream signaling pathways (6-8). LAT is palmitoylated, efficient than Grb2's interactions with the same molecules. The pre-TCR and TCR are involved in the sequential which targets it to membrane lipid rafts (9), and it is tyrosine phosphorylated upon TCR stimulation. Several signaling moledevelopment of T cells in the thymus. The CD4 -CD8 -doublenegative (DN) thymocytes make up the most immature T cell cules, such as Grb2, PLC-γ1 and the 85 kDa subunit of phosphoinositol-3-kinase, bind to phosphotyrosine residues subset, which is subdivided into four discrete stages as follows: CD25 -CD44 ϩ → CD25 ϩ CD44 ϩ → CD25 ϩ CD44 -→ of LAT through their SH2 domains (7). We and others independently isolated cDNA clones coding for the same novel CD25 -CD44 - (17) . The pre-TCR complex, which consists of a successfully rearranged TCR β chain, pre-TCR α chain member of the Grb2 family, which is called Gads, Grf40, GrpL, Mona, Grap2 or GRID (10-15). Gads contains an SH2 and components of the CD3 complex, is expressed at the CD25 ϩ CD44 -pre-T cell stage, and the pre-TCR signaling is and two SH3 domains, and is constitutively associated with SLP-76 through its C-terminal SH3 domain, and binds to LAT necessary and sufficient for sustained survival, proliferation
and progression of the DN T cells into the CD4 ϩ CD8 ϩ doublepositive (DP) T cells (18). Knockout mice lacking either SLP-76 or LAT show a complete block in thymic development, with the presence of the DN subset but the absence of the DP and CD4 ϩ CD8 -(CD4SP) or CD4 -CD8 ϩ single-positive (CD8SP) subsets, indicating that both SLP-76 and LAT are critically involved in the pre-TCR signaling (19) (20) (21) .
To investigate the in vivo functional significance of Gads' interactions with SLP-76 and LAT, we generated transgenic mice expressing a dominant-negative form of Gads, Grf40-dSH2, in thymocytes, and demonstrated the possible involvement of Gads in thymocyte development at the pre-T cell stage.
Methods

Plasmids and transgenic mice
cDNA fragments of a human Gads mutant with its SH2 domain deleted, Grf40-dSH2, were amplified by PCR from the plasmid pMycGrf40-dSH2 (11). The Grf40-dSH2 cDNA was inserted into the BamHI sites of the p1017 vector, which contains the lck proximal promoter and the human growth hormone genomic fragment to provide efficient splicing and expression of the transgene (Fig. 1A) (22) . To generate transgenic mice, the Grf40-dSH2 fragment (6.1 kb) was excised by digestion with NotI, purified and injected into C57BL/Cr fertilized eggs (Fig. 1A) . Four founder mice were identified by PCR from tail DNA, using a forward primer, TGGGAGGCAGGAAGTG-GGTAACTAGACTAA, which binds within the lck proximal promoter and a reverse primer, CTTGGTTACTTAAAATCT-TCAAAACATCTC, which binds to the N-terminal SH3 region of the Gads sequence. The resulting product is a 0.3-kb fragment. One of the founder mice died for unknown reasons, and three transgenic lines, dnGads-1, dnGads-2 and dnGads-3, were obtained. The dnGads-1 and dnGads-2 lines contained 60-80 copies of the transgene, and the dnGads-3 line contained three copies.
Purification of DN thymocytes
The DN thymocyte subset was purified by auto-MACS (Miltenyi Biotec, Auburn, CA). In brief, 9.0ϫ10 8 total thymocytes were body was used after labeling with FITC. When necessary, thymocyte number was also reduced in both 3-to 4-and 8-to 9-week-old mice (P ϭ 0.0002).
cells were further stained with streptavidin-allophycocyanin. , dnGads-1 ϩ/-(n ϭ 6) and dnGads-1 ϩ/ϩ (n ϭ 9) mice was assessed using anti-CD4-PE and anti-CD8-FITC mAb. The average percentage (mean Ϯ SEM) of the total is shown for each subset. (B) All the thymocyte subsets except for the DN subset were reduced in the transgenic mice. The absolute cell numbers of wild-type (s) or dnGads-1 ϩ/-( ) mice were calculated based on the percentages obtained after CD4 and CD8 staining, and the total thymocyte numbers of 3-to 4-week-old mice given in (A). Mean values are indicated by the filled bars. P values are shown, where significance was indicated by Student's t-test. (C) The subpopulations of the DN thymocyte subset were detected with anti-CD25-biotin, streptavidin-allophycocyanin and anti-CD44-CyChrome mAb. Thymocytes were prepared from wild-type (n ϭ 12), dnGads-1 ϩ/-(n ϭ 9) and dnGads-1 ϩ/ϩ (n ϭ 7) mice. The average percentage (mean Ϯ SEM) of the total is shown for each subset. In the CD25/CD44 analysis, cells expressing any one of the CD8, CD4, B220, NK1.1, TER-119, Mac-1 or Gr-1 markers were excluded from the analysis. 
Thymocyte stimulation and immunoblot analysis
Thymocytes (1ϫ10 7 ) were suspended in 300 µl of ice-cold PBS containing 10 µg/ml biotinylated anti-mouse CD3ε (PharMingen) and incubated on ice for 20 min. They were washed with ice-cold PBS and cross-linked with 100 µl of pre-warmed PBS containing 20 µg/ml streptavidin (Wako Pure Chemical, Osaka, Japan) at 37°C for the indicated times. Immunoblotting was carried out as described previously (24) . In brief, the stimulated thymocytes were lysed with lysis buffer (150 mM NaCl, 2 mM EDTA, 1.0% NP-40, 40 mM Tris-HCl, pH 7.6, 0.1% DMSO, 1.0% aprotinin, 1 mM PMSF and 1 mM Na 3 VO 4 ). The lysates (10 µg of protein per lane) were fractionated by SDS-PAGE then transferred to PVDF filters (Millipore, Bedford, MA). After incubation in TBS containing 3.0% BSA or 5.0% skim milk and 0.1% Tween 20, the filters were probed with the indicated antibodies and visualized using the ECL detection system (Amersham Pharmacia Biotech, Rainham, UK). The antibodies used were anti-Gads polyclonal rabbit antibody (anti-Grf40), anti-phosphotyrosine Ab (4G10), anti-SLP-76 Ab (Upstate Biotechnology, Lake 
Generation of transgenic mice expressing a dominant-nega-
fluorescence intensity of the wild-type and the dnGads-1 ϩ/ϩ mice tive form of Gads were 270 Ϯ 14 (n ϭ 4) and 177 Ϯ 13 (n ϭ 7) respectively (P ϭ 0.0015).
A human dominant-negative Gads mutant, Grf40-dSH2, was inserted into the p1017 expression vector, which contains the thymocyte-specific lck proximal promoter (22) (Fig. 1A) . Using numbers (mean Ϯ SEM) of the wild-type, dnGads-1 ϩ/-, this vector, we established three lines of Grf40-dSH2 transdnGads-1 ϩ/ϩ and dnGads-2 ϩ/-mice were 18.5 Ϯ 1.1ϫ10 7 , genic mice, dnGads-1, dnGads-2, and dnGads-3, which 8.0 Ϯ 0.8ϫ10 7 , 2.0 Ϯ 0.4ϫ10 7 and 11.2 Ϯ 0.6ϫ10 7 respectexpressed Grf40-dSH2 as well as the endogenous wildively at 3-4 weeks of age. At 8-9 weeks of age, the average type Gads. Thymocytes from dnGads-1 ϩ/-, dnGads-1 ϩ/ϩ and thymocyte numbers of the wild-type, dnGads-1 ϩ/-and dnGads-2 ϩ/-mice expressed Grf40-dSH2 at levels that were dnGads-2 ϩ/-mice were 22.1 Ϯ 1.5ϫ10 7 , 8.3 Ϯ 0.4ϫ10 7 and 9-, 15-and 10-fold higher respectively than the expression of 9.1 Ϯ 0.5ϫ10 7 respectively (Fig. 1C) . Because the expression the endogenous wild-type Gads in the same animals. In level of Grf40-dSH2 was the highest in dnGads-1 ϩ/ϩ mice, contrast, dnGads-1 -/-and dnGads-2 -/-mice showed no compared with the dnGads-1 ϩ/-and dnGads-2 ϩ/-mice (Fig. expression of Grf40-dSH2, and dnGads-3 ϩ/-mice expressed 1B), the severity of thymocyte reduction seemed to depend Grf40-dSH2 at a 10th the level that wild-type Gads was on the amount of the transgene expressed. We thus demonexpressed in thymocytes (Fig. 1B) . The lck proximal promoter strated that one characteristic of the Grf40-dSH2 transgenic is known to be strongly active in all thymocyte subsets, mice is a disturbance of thymocyte development. including the CD4 -CD8 -, CD4 ϩ CD8 ϩ , CD4 ϩ CD8 -and CD4 - To analyze more precisely the reduction of thymocyte CD8 ϩ thymocytes, but weakly active in peripheral T cells or numbers in the transgenic mice, the T cell subset profile other tissues (22, 25) . Accordingly, we detected expression was examined using CD4 and CD8 surface markers. The of Grf40-dSH2 in the thymocytes, but not in the splenocytes percentage of DN subpopulation was increased Ͼ5-and Ͼ2-of the transgenic mice (data not shown). We chose to use fold in dnGads-1 ϩ/ϩ and dnGads-1 ϩ/-mice respectively (Fig.  the dnGads-1 and dnGads-2 lines for further study.
2A), an increase that correlated with the amounts of the transgene expressed (Fig. 1B) .
The absolute numbers of cells Developmental defects of DN thymocytes in dnGads mice
in the thymocyte subsets including the DN, DP, CD4SP and CD8SP subsets were calculated based on the data from the To investigate the effect of the Grf40-dSH2 transgene on thymic development, we first examined the absolute thymo-FACS analyses, and all the subsets except for the DN subset were significantly decreased (Fig. 2B ). cyte numbers of the transgenic mice. The average thymocyte The percentage of CD25 ϩ CD44 -pre-T cell population of the DN subset was significantly increased in dnGads-1 ϩ/ϩ and dnGads-1 ϩ/-mice, compared with wild-type mice (Fig.  2C) . A similar increase in the same thymocyte population was also observed in the dnGads-2 ϩ/-mice (data not shown). We further estimated the absolute cell number of each subpopulation of DN thymocytes (Fig. 2D) . Only the CD25 ϩ CD44 -subpopulations of the DN subset was significantly increased in the dnGads-1 ϩ/-mice as compared with the wild-type mice. We also confirmed the expression of Grf40-dSH2 in the DN thymocytes of the dnGads-1 ϩ/-and dnGads-2 ϩ/-mice along with the expression of the wild-type Gads and Grb2 (Fig. 3A) . These results suggest that the expression of the dominant-negative Gads mutant, Grf40-dSH2, induces suppression of thymic development at the CD25 ϩ CD44 -pre-T cell stage of the DN thymocytes.
The pre-T cells of the DN subset express the pre-TCR complex, the stimulation of which is indispensable for their further development into DP thymocytes (18). In addition, the expression of CD5 on DN thymocytes is known to be induced by pre-TCR stimulation (26). Hence, we compared CD5 expression on thymocytes between the transgenic and wildtype mice. The expression of CD5 on DN thymocytes was significantly lower in dnGads-1 ϩ/ϩ mice than in wild-type mice (Fig. 3B) . These results also support the possibility that the pre-TCR signaling in the DN subset is impaired by the expression of the Grf40-dSH2 transgene and that the impaired in Jurkat cells (11). Hence we investigated the dominantnegative effect of Grf40-dSH2 on TCR signaling in thymocytes. Thymocytes stimulated with an anti-CD3 mAb were examined Discussion for tyrosine phosphorylation of SLP-76 and ZAP-70. The tyrosine phosphorylation of SLP-76 was significantly induced Grf40-dSH2, which contains the SH3 domains, is thought to in dnGads-1 -/-thymocytes, but was markedly reduced to an have a dominant-negative effect on Grb2 as well as Gads, in undetectable level in dnGads-1 ϩ/ϩ thymocytes. However, the the SLP-76-dependent signaling, since Gads and Grb2 are tyrosine phosphorylation of ZAP-70, although weakly induced associated with both SLP-76 and LAT (10-12,27). The two in both dnGads-1 -/-and dnGads-1 ϩ/ϩ thymocytes, may indiindependent lines of Grf40-dSH2 transgenic mice that we cate that ZAP-70 is normally activated by TCR stimulation in describe here showed similar characteristics of suppressed the thymocytes of the transgenic mice (Fig. 4A) . Nevertheless, thymic development at the CD25 ϩ CD44 -pre-T cell stage. A the subsequent tyrosine phosphorylation of SLP-76 is appredevelopmental defect at the pre-T cell stage was also seen ciably blocked by the expression of Grf40-dSH2. Because in knockout mice lacking either SLP-76 or LAT, and both SLP-SLP-76 is involved in the downstream signaling of the TCR 76 and LAT are known to be involved in the pre-TCR as well complex leading to activation of the p44/42 MAP kinase (ERK1/ as TCR signaling (19) (20) (21) . Although we have not yet obtained 2) and PLC-γ1 (6), we further examined the phosphorylation of direct evidence for the impairment of the pre-TCR signaling PLC-γ1 and ERK1/2 in thymocytes upon anti-CD3 stimulation.
Failure of SLP-76-dependent signaling pathways in dnGads
in the Grf40-dSH2 transgenic mice, we suspect that the The phosphorylation levels of both PLC-γ1 and ERK1/2 were accumulation of pre-T cells in the thymi of the Grf40-dSH2 profoundly reduced in dnGads-1 ϩ/ϩ thymocytes as compared transgenic mice results from a dysfunction in the pre-TCR with dnGads-1 -/-thymocytes (Fig. 4B) . These results suggest signaling pathway caused by the dominant-negative effect that the TCR signaling was suppressed in the thymocytes of Grf40-dSH2. Actually, the SLP-76-dependent signaling expressing Grf40-dSH2 by a block in the SLP-76-dependpathway mediated by TCR stimulation was significantly impaired in the thymocytes of the transgenic mice. On the ent pathway. other hand, it has been found that the decreased expression Abbreviations of Grb2 in Grb2 haploid insufficient (Grb2 ϩ/-) mice causes and Grb2 are associated with both SLP-76 and LAT, we
